← Back to Search

Treatment for Vasculitis (PedVas Trial)

N/A
Recruiting
Led By Susanne Benseler, MD, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 3 yrs
Awards & highlights

Summary

This trial is studying a group of rare, life-threatening diseases that have in common inflammation of blood vessels in vital organs.

Eligible Conditions
  • Vasculitis
  • Microscopic Polyangiitis
  • Takayasu Arteritis
  • Wegener's Granulomatosis
  • Churg-Strauss Syndrome
  • Polyarteritis Nodosa
  • Primary Central Nervous System Vasculitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 3 yrs
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3 yrs for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Develop new benchmarks for outcome in pediatric patients with systemic vasculitis

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,451 Previous Clinical Trials
2,481,590 Total Patients Enrolled
1 Trials studying Vasculitis
201 Patients Enrolled for Vasculitis
BC Childrens Hospital Research InstituteUNKNOWN
Simon Fraser UniversityOTHER
56 Previous Clinical Trials
8,978 Total Patients Enrolled
~55 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top